Agile Therapeutics, Inc. (AGRX) Social Stream
AGILE THERAPEUTICS INC (AGRX) Price Targets From Analysts
Use the tables below to see what analysts covering AGILE THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 5 | $5 | $2.5 | $3.875 | $1.56 | 148.4% |
| 2021-11-26 | 5 | $5 | $2 | $3.375 | $1.56 | 116.35% |
| 2022-01-20 | 3 | $5 | $2 | $3.375 | $1.56 | 116.35% |
| 2022-03-31 | 3 | $200 | $60 | $110 | $1.56 | 6951.28% |
| 2022-07-11 | 2 | $80 | $5 | $42.5 | $1.56 | 2624.36% |
| 2022-08-19 | 2 | $5 | $1 | $3 | $1.56 | 92.31% |
| 2022-12-30 | 2 | $3 | $1 | $2 | $1.56 | 28.21% |
| 2023-06-26 | 2 | $12 | $12 | $12 | $1.56 | 669.23% |
| 2023-10-02 | 2 | $12 | $5 | $8.5 | $1.56 | 444.87% |
The Trend in the Analyst Price Target
Over the past 40 months, AGRX's average price target has gone up $1.3.
Over the past 117 days, AGRX's average upside potential has been 294.2%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-07 | 2 | 12 | 12 | 12.0 | 3.68 | 226.09% |
| 2023-06-26 | 2 | 12 | 12 | 12.0 | 2.73 | 339.56% |
| 2023-09-22 | 2 | 12 | 5 | 8.5 | 1.76 | 382.95% |
| 2023-10-02 | 2 | 12 | 5 | 8.5 | 2.59 | 228.19% |
AGRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 43 weeks, AGRX's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AGRX as an investment opportunity.
- In terms of how AGILE THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 98.74% of that group.
- AGILE THERAPEUTICS INC's variance in analysts' estimates is lower than -953.25% of all US stocks.
- AGILE THERAPEUTICS INC's average analyst price target is greater than 475.22% of Pharmaceutical Products stocks.
- In the context of stocks in the micro market cap category, AGILE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 886.53% of them.
Stocks similar to AGILE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PHIO, ORGS, and EVOK.
View All Top Stocks by Price Target
What is the outlook for AGRX? Use POWR Ratings for clearer insight into price direction.